{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:38:21Z","timestamp":1790933901635,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL089405"],"award-info":[{"award-number":["R01 HL089405"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL115265"],"award-info":[{"award-number":["HL115265"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s10020-018-0037-2","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T12:23:27Z","timestamp":1531830207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Myocyte-specific overexpressing HDAC4 promotes myocardial ischemia\/reperfusion injury"],"prefix":"10.1186","volume":"24","author":[{"given":"Ling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja M.","family":"Dubielecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shougang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangjian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y Eugene","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Race L.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting C.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"issue":"6","key":"37_CR1","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.cell.2008.04.041","volume":"133","author":"T Ago","year":"2008","unstructured":"Ago T, Liu T, Zhai P, Chen W, Li H, Molkentin JD, Vatner SF, Sadoshima J. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell. 2008;133(6):978\u201393.","journal-title":"Cell"},{"key":"37_CR2","doi-asserted-by":"publisher","first-page":"28930","DOI":"10.1074\/jbc.M303113200","volume":"278","author":"CL Antos","year":"2003","unstructured":"Antos CL, McKinsey TA, Dreitz M, Hollingsworth LM, Zhang CL, Schreiber K, Rindt H, Gorczynski RJ, Olson EN. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem. 2003;278:28930\u20137.","journal-title":"J Biol Chem"},{"issue":"10","key":"37_CR3","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1073\/pnas.1015081108","volume":"108","author":"DJ Cao","year":"2011","unstructured":"Cao DJ, Wang ZV, Battiprolu PK, Jiang N, Morales CR, Kong Y, Rothermel BA, Gillette TG, Hill JA. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A. 2011;108(10):4123\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"37_CR4","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1002\/jcb.23251","volume":"112","author":"HP Chen","year":"2011","unstructured":"Chen HP, Denicola M, Qin X, Zhao Y, Zhang L, Long XL, Zhuang S, Liu PY, Zhao TC. HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway. J Cell Biochem. 2011;112:3246\u201355.","journal-title":"J Cell Biochem"},{"issue":"6","key":"37_CR5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/jcp.24871","volume":"230","author":"J Du","year":"2015","unstructured":"Du J, Zhang L, Zhuang S, Qin GJ, Zhao TC. HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia\/reoxygenation injury. J Cell Physiol. 2015;230(6):1321\u201331.","journal-title":"J Cell Physiol"},{"key":"37_CR6","doi-asserted-by":"publisher","first-page":"11713","DOI":"10.1074\/jbc.274.17.11713","volume":"274","author":"W Fischle","year":"1999","unstructured":"Fischle W. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J Biol Chem. 1999;274:11713\u201320.","journal-title":"J Biol Chem"},{"key":"37_CR7","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1096\/fj.08-108548","volume":"22","author":"A Granger","year":"2008","unstructured":"Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T, Epstein JA, Gruber PJ. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J. 2008;22:3549\u201360.","journal-title":"FASEB J"},{"key":"37_CR8","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","volume":"96","author":"CM Grozinger","year":"1999","unstructured":"Grozinger CM, Hassig CA, Schreiber SL. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A. 1999;96:4868\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"37_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32\u201342.","journal-title":"Nat Rev Genet"},{"key":"37_CR10","doi-asserted-by":"crossref","unstructured":"Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, Schreiber SL. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci U S A. 1998;95:3519\u201324.","DOI":"10.1073\/pnas.95.7.3519"},{"key":"37_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","volume":"113","author":"HJ Kee","year":"2006","unstructured":"Kee HJ, Sohn IS, KIl N, Park JE, Qian YR, Yin Z, Ahn Y, Jeong MH, Bang YJ, Kim N, Kim JK, Kim KK, Epstein JA, Kook H. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation. 2006;113:51\u20139.","journal-title":"Circulation"},{"key":"37_CR12","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","volume":"113","author":"Y Kong","year":"2006","unstructured":"Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation. 2006;113:2579\u201388.","journal-title":"Circulation"},{"key":"37_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","volume":"52","author":"TA McKinsey","year":"2012","unstructured":"McKinsey TA. Therapeutic potential for HDAC inhibitors in the heart. Annu Rev Pharmacol Toxicol. 2012;52:303\u201319.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"37_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nm1552","volume":"13","author":"CM Trivedi","year":"2007","unstructured":"Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, Ferrari VA, Abrams CS, Gruber PJ, Epstein JA. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med. 2007;13(3):324\u201331.","journal-title":"Nat Med"},{"key":"37_CR15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X","volume":"22","author":"BM Turner","year":"2000","unstructured":"Turner BM. Histone acetylation and an epigenetic code. BioEssays. 2000;22:836\u201345.","journal-title":"BioEssays"},{"key":"37_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0168-9525(03)00073-8","volume":"19","author":"E Verdin","year":"2003","unstructured":"Verdin E, Dequiedt F, Kasler HG. Class II histone deacetylases: versatile regulators. Trends Genet. 2003;19:286\u201393.","journal-title":"Trends Genet"},{"key":"37_CR17","doi-asserted-by":"publisher","first-page":"7816","DOI":"10.1128\/MCB.19.11.7816","volume":"19","author":"AH Wang","year":"1999","unstructured":"Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th\u2019ng J, Han J, Yang XJ. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol. 1999;19:7816\u201327.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"37_CR18","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1002\/jcp.25857","volume":"232","author":"H Wang","year":"2017","unstructured":"Wang H, Zhao YT, Zhang S, Dubielecka PM, Du J, Yano N, Chin YE, Zhuang S, Qin G, Zhao TC. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury. J Cell Physiol. 2017;232(12):3775\u201385.","journal-title":"J Cell Physiol"},{"issue":"4","key":"37_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","volume":"110","author":"CL Zhang","year":"2012","unstructured":"Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 2012c;110(4):479\u201388.","journal-title":"Cell"},{"key":"37_CR20","doi-asserted-by":"publisher","first-page":"39338","DOI":"10.1074\/jbc.M112.379115","volume":"287","author":"L Zhang","year":"2012","unstructured":"Zhang L, Chen B, Zhao Y, Dubielecka PM, Wei L, Qin GJ, Chin YE, Wang Y, Zhao TC. Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts. J Biol Chem. 2012a;287:39338\u201348.","journal-title":"J Biol Chem"},{"issue":"8","key":"37_CR21","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/jcb.25902","volume":"118","author":"L Zhang","year":"2017","unstructured":"Zhang L, Du J, Yano N, Wang H, Zhao YT, Dubielecka PM, Zhuang S, Chin YE, Qin G, Zhao TC. Sodium butyrate protects -against high fat diet-induced cardiac dysfunction and metabolic disorders in type II diabetic mice. J Cell Biochem. 2017;118(8):2395\u2013408.","journal-title":"J Cell Biochem"},{"key":"37_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1124\/jpet.111.189910","volume":"341","author":"L Zhang","year":"2012","unstructured":"Zhang L, Xin Q, Zhao Y, Fast L, Zhuang S, Liu P, Cheng G, Zhao TC. Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J Pharmacol Exp Ther. 2012b;341:285\u201393.","journal-title":"J Pharmacol Exp Ther"},{"key":"37_CR23","doi-asserted-by":"publisher","first-page":"H2154","DOI":"10.1152\/ajpheart.01015.2009","volume":"298","author":"LX Zhang","year":"2010","unstructured":"Zhang LX, Zhao Y, Cheng G, Guo TL, Chin YE, Liu PY, Zhao TC. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. Am J Physiol Heart Circ Physiol. 2010;298:H2154\u201363.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"37_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cardiores.2007.08.010","volume":"76","author":"TC Zhao","year":"2007","unstructured":"Zhao TC, ChengG ZLX, Tseng YT, Padbury JF. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res. 2007;76:473\u201381.","journal-title":"Cardiovasc Res"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-018-0037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10020-018-0037-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-018-0037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T15:58:09Z","timestamp":1589558289000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-018-0037-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1186\/s10020-018-0037-2","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,17]]},"assertion":[{"value":"22 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal study protocol was approved by the Institutional Animal Care and Use Committee of Roger Williams Medical Center and the East Tennessee State University Committee on Animal Care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"37"}}